ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9
Authors:
- Lena CookLCLena Cook
- Marie SengelmannMSMarie Sengelmann
- Birte WinklerBWBirte Winkler
- Constanze NaglCNConstanze Nagl
- Sarah KochSKSarah Koch
- Uwe SchlomannUSUwe Schlomann
- Emily P. SlaterESEmily P. Slater
- Miles A. MillerMMMiles A. Miller
- Elke Pogge von StrandmannESElke Pogge von Strandmann
- Bastian DörsamBDBastian Dörsam
- Christian PreußerCPChristian Preußer
- Jörg W. BartschJörg W. Bartsch
Open Access
- 10 February 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 1976
Abstract
The metalloprotease-disintegrin ADAM8 is critically involved in the progression of pancreatic cancer. Under malignant conditions, ADAM8 is highly expressed and could play an important role in cell–cell communication as expression has been observed in tumor and immune cells of the tumor microenvironment (TME) such as macrophages. To analyze the potential role of ADAM8 in the TME, ADAM8 knockout PDAC tumor cells were generated, and their release of extracellular vesicles (EVs) was analyzed. In EVs, ADAM8 is present as an active protease and associated with lipocalin 2 (LCN2) and matrix metalloprotease 9 (MMP-9) in an ADAM8-dependent manner, as ADAM8 KO cells show a lower abundance of LCN2 and MMP-9. Sorting of ADAM8 occurs independent of TSG101, even though ADAM8 contains the recognition motif PTAP for the ESCRTI protein TSG101 within the cytoplasmic domain (CD). When tumor cells were co-cultured with macrophages (THP-1 cells), expression of LCN2 and MMP-9 in ADAM8 KO cells was induced, suggesting that macrophage signaling can overcome ADAM8-dependent intracellular signaling in PDAC cells. In co-culture with macrophages, regulation of MMP-9 is independent of the M1/M2 polarization state, whereas LCN2 expression is preferentially affected by M1-like macrophages. From these data, we conclude that ADAM8 has a systemic effect in the tumor microenvironment, and its expression in distinct cell types has to be considered for ADAM8 targeting in tumors.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (BA1606/3-1, BA1606/4-1, SL17/5-1, GRK2573/1)
This publication has 30 references indexed in Scilit:
- Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expressionMedical Oncology, 2014
- ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasisEMBO Molecular Medicine, 2013
- HIV Nef, Paxillin, and Pak1/2 Regulate Activation and Secretion of TACE/ADAM10 ProteasesMolecular Cell, 2013
- Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membraneJournal of Extracellular Vesicles, 2013
- Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 proteinProceedings of the National Academy of Sciences, 2012
- Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activitiesIntegrative Biology, 2011
- The Metalloprotease-Disintegrin ADAM8 Is Essential for the Development of Experimental AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusionBMC Microbiology, 2009
- ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancerJournal of Cellular and Molecular Medicine, 2007
- The shedding activity of ADAM17 is sequestered in lipid raftsExperimental Cell Research, 2006